Skip to content
Wenlo
Sign in
← Markets

Guardant Health, Inc.

Guardant Health, Inc. (GH) — Form 144: Proposed sale of shares

144GHFiled Nov 18, 2026, 4:09 PM ET

AI-generated summary

Officer Monroe Terilyn J. of Guardant Health, Inc. proposed to sell 3,842 common shares with an aggregate market value of $547,149 through Charles Schwab & Co., Inc. on approximately November 18, 2026. The shares to be sold were acquired through restricted stock lapses of 1,921 shares on July 1, 2026, and 1,921 shares on October 1, 2026. The proposed sale was made under a trading plan adopted on August 19, 2026.

Key facts

Seller
Monroe Terilyn J.
Relationship
Officer
Shares to sell
3,842
Market value
$547,149.00
Approximate sale date
Nov 18, 2026
Broker
Charles Schwab & Co., Inc.
Acquired (1)
Jul 1, 2026 · Restricted Stock Lapse
Acquired (2)
Oct 1, 2026 · Restricted Stock Lapse

Rule 10b5-1 plan · adopted Aug 19, 2026

More GH filings

Not investment advice. Summaries can contain errors; the SEC filing is the official record.